Embryonal Neoplasm — Trials

Embryonal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–50 of 135 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04616560	Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor	recruiting	Phase 2	55	National Cancer Institute (NCI)NIH	1	Sep 29, 2026	clinicaltrials
NCT07346157	Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease(PNOC044)	recruiting	Phase 1 / Phase 2	69	Sabine Mueller, MD, PhDOTHER	1	Sep 28, 2026